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Abstract
We examined the extent to which studies aimed at testing interventions to improve antiretroviral
adherence have targeted the facilitators of and barriers known to affect adherence. Of the 88 reports
reviewed, 41 were reports of descriptive studies conducted with U.S. HIV-positive women and 47
were reports of intervention studies conducted with U.S. HIV-positive persons. We extracted from
the descriptive studies all findings addressing any factor linked to antiretroviral adherence and from
the intervention studies, information on the nature of the intervention, the adherence problem
targeted, the persons targeted for the intervention, and the intervention outcomes desired. We
discerned congruence between the prominence of substance abuse as a factor identified in the
descriptive studies as a barrier to adherence and its prominence as the problem most addressed in
those reports of intervention studies that specified the problems targeted for intervention. We also
discerned congruence between the prominence of family and provider support as factors identified
in the descriptive studies as facilitators of adherence and the presence of social support as an
intervention component and outcome variable. Less discernible in the reports of intervention studies
was specific attention to other factors prominent in the descriptive studies, which may be due to the
complex nature of the problem, individualistic and rationalist slant of interventions, or simply the
ways interventions were presented. Our review raises issues about niche standardization and
intervention tailoring, targeting, and fidelity.
Reviews of descriptive studies have shown the many and varied factors influencing
antiretroviral adherence (e.g., Ammassari et al., 2002; Mills et al., 2006; Vervoort, Borleffs,
Hoepelman, & Grypdonck, 2007). Reviews of intervention studies indicate that the active
component has yet to be identified that will produce consistently desirable adherence rates
(e.g., Rueda et al., 2006; Rivet Amico, Harman, & Johnson, 2006; Simoni, Pearson, Pantalone,
Marks, & Crepaz, 2006). The use of diverse measurements of adherence (Liu et al., 2001;
Mannheimer et al., 2008; Paterson, Potoski, & Capitano, 2002), and recent findings that the
levels of adherence required to achieve viral suppression and prevent drug resistance may vary
with drug regimen (e.g., Bangsberg et al., 2006), complicate efforts to understand and improve
adherence.
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Intervention studies ought to be firmly grounded in empirically-based understandings of the
problems to be targeted (Sidani & Braden, 1998). However, the congruence between factors
identified through empirical studies to influence adherence and the targets of interventions
designed to enhance adherence has not yet been explored. The purpose of the systematic review
reported here was to ascertain the extent to which a set of antiretroviral adherence intervention
studies targeted the facilitators of and barriers to adherence identified in a set of antiretroviral
adherence descriptive studies.
Method
This systematic review was conducted in the course of a research project aimed at developing
methods to synthesize qualitative and quantitative research findings. Search and retrieval
procedures were thus selected to accommodate methodological objectives, not to answer
research questions about antiretroviral adherence per se. The goal was to obtain a well-defined
but manageable sample of research reports with sufficient methodological diversity (i.e.,
different types of qualitative and quantitative studies) and topical uniformity (all on
antiretroviral adherence) to permit the intensive analysis and experimentation with technique
required in a study of methods. Specifically, we confined our search to published reports as
unpublished reports contained no methodological variation not found in published reports. We
confined our search to studies conducted in the United States as national differences in
healthcare delivery and attitudes toward HIV infection would have added a level of complexity
to analysis that would not advance the methodological aims of our study. We confined our
search for descriptive studies to those conducted with women only. Reviews of studies
conducted with men and women or men only (e.g., those cited above) indicate no factor
influencing adherence not also found in women-only studies. Yet, additional factors are found
in women-only studies (e.g., those related to reproduction and mothering); indeed, women’s
unique circumstances are often cited in reports of women-only studies as justifications for
studying women only. Men-only descriptive studies can, thus, be considered a subset of
women-only descriptive studies. Antiretroviral intervention studies conducted with women
and men can be assumed to address factors common to both. All of these sampling delimitations
constitute limitations to the review presented here, yet all systematic reviews entail such
limitations (Sandelowski, Voils, & Barroso, 2007).
Forty-one reports of antiretroviral adherence descriptive (14 qualitative and 27 quantitative
observational) studies were retrieved between June, 2005 and October, 2007. Forty-seven
reports of antiretroviral intervention studies were retrieved in October, 2007. We used
electronic databases housing citations to literature across the health, behavioral, and social
sciences, including Academic Search Elite, Alternative Press Index, Cochrane Central Register
of Controlled Trials, Cumulative Index to Nursing and Allied Health Literature (CINAHL),
PsycINFO, PubMed, and Sociological Abstracts. We used variations (e.g., extensions,
truncations, synonyms) of the following search terms to accommodate the distinctive features
of each of these databases: HIV, AIDS, antiretroviral, adherence, compliance, clinical trial,
intervention, and experiment. We augmented electronic searching with the use of ancestry and
descendency approaches (Cooper, 1998), in addition to hand-searching the print collections of
our university libraries for books, anthologies, and other documents on HIV/AIDS likely to
include relevant reports.
Antiretroviral Descriptive Studies
Reports of descriptive studies were eligible for inclusion if they were of empirical qualitative
and quantitative observational studies of adherence to antiretroviral therapy conducted with
HIV-positive women of any race/ethnicity, class, or nationality living in the United States, and
published in or after 1997 (when protease inhibitors became part of the standard of care) to the
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present (2007). We accepted reports of studies conducted with HIV-positive women that
included HIV-positive men if an explicit research purpose was to compare women and men in
relation to antiretroviral adherence and if the report contained findings focused on women.
We extracted from the qualitative studies all findings addressing any aspect of antiretroviral
adherence and calculated their frequency effect sizes, or the number of reports containing a
finding divided by the total number of reports (Sandelowski & Barroso, 2007). We extracted
from the quantitative observational studies all relationships addressing adherence and another
variable, and computed their effect sizes. The effect size index that we used is Cohen’s d
(Cohen, 1988), which is the standardized difference between two means (in these studies, the
difference in mean adherence between two groups, such as drug users versus non-users).
Calculating d enables comparisons to be made across studies because all differences in means
are on the same scale. A value of 0 indicates no difference between means. Cohen suggested
that values of .20, .50, and .80 represent small, medium, and large differences, respectively.
Because we would not expect interventions to address factors that have not been shown to be
related to adherence, we excluded findings that did not meet the criterion for a “small” effect
size (i.e., any d < .20) in quantitative research. We used effect sizes instead of p-values, which
are influenced by sample size to a greater degree (Rosenthal, 1984). We also excluded findings
for which there was insufficient information for calculating an effect size even after contacting
the authors. Whenever only bivariate or only multivariable findings were addressed in a report,
we retained those findings, but in reports in which the same variable was addressed in both
bivariate and multivariable analyses, we used the bivariate relationship. This is because an
effect size for a partial relationship may be greater or lesser, depending on which variables are
chosen to be included in the multivariable model. Multivariable findings, therefore, are less
comparable than bivariate findings because they estimate different partial relationships (Voils,
Barroso, Hasselblad, & Sandelowski, 2007).
We then grouped these findings into categories and the findings within these categories into
factors favoring adherence and nonadherence. (Tables showing the results of these data
extractions and computations are available from the first author on request.)
Antiretroviral Intervention Studies
Reports of intervention studies were eligible for inclusion if they were of studies published in
or after 2000 to the present (2007) of any kind of intervention designed to improve antiretroviral
adherence in any HIV-positive person living in the United States. We selected the year 2000
to accommodate the time it likely took for findings from adherence descriptive studies to make
their way into adherence intervention studies. We included intervention studies conducted with
both women and men as too few adherence intervention studies have targeted women only.
We included all designs, including randomized controlled trials, nonrandomized studies, and
within-subject studies with pre-post tests. We excluded reports of pilot studies if a later report
testing the same intervention in a larger sample was available so that each intervention would
be counted only once.
We extracted and tabulated information from each report on the nature of the intervention, the
adherence problem targeted, the persons targeted for the intervention, and the intervention
outcomes desired. Table 1 shows the results of this work.
Report Quality and Procedural Validity
All reports were reviewed by the first two authors, and all extractions, tabulations, and
computations of findings were checked by at least two members of the research team, or
discussed until consensus was reached in meetings of the entire research team. No reports of
qualitative studies that met selection criteria were excluded for reasons of quality per se as any
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methodological shortcomings they showed did not invalidate their findings (Sandelowski &
Barroso, 2007). Entire reports of quantitative observational studies that met selection criteria,
or specific findings in these reports, were excluded only if it was not possible (even with
attempts to contact authors) to calculate effect sizes. No reports of intervention studies that met
selection criteria were excluded as our goal was not to summarize their findings, but rather the
problems and persons targeted for intervention and the interventions tested.
Results
Factors Influencing Adherence in Descriptive Studies
The categories of factors most prominent (i.e., appearing in the largest number of different
reports) in favoring adherence were: sociocultural factors (14 reports); relationship with
healthcare provider (10 reports); attitudes toward and beliefs about HIV infection and
antiretroviral therapy (9 reports); and, medication regimen and motivation/inclination to act (8
reports each). The factors favoring adherence appearing in the largest number of different
reports across categories were: having a supportive family and having a supportive provider
(6 reports each), and believing in the effectiveness and safety of antiretroviral therapy (5
reports).
The categories of factors most prominent in favoring nonadherence were: medication regimen
(14 reports); sociocultural factors, and attitudes toward and beliefs about HIV infection and
antiretroviral therapy (12 reports each), and substance abuse (including drug and alcohol abuse,
11 reports). In addition to the 11 reports comprising the substance abuse category, the most
prominent factors across categories favoring nonadherence were: having side effects (13
reports); not wanting others to know HIV status (7 reports); and, uncertainty about the
effectiveness and safety of antiretroviral medications and having no symptoms from HIV (6
reports each).
Factors Targeted in the Intervention Studies
The primary focus of the intervention reports—to improve adherence to antiretroviral therapy
—was operationalized in different ways (e.g., adherence to dose or schedule, as measured by
number or percentage of missed pills, self-report, pill counts, or Medication Event Monitoring
System caps). Of the 47 reports, 23 featured outcome measures in addition to adherence, such
as self-efficacy, social support, and a range of mental health indicators.
As shown in Table 1, the only persons targeted for intervention were HIV-positive persons
themselves. Among HIV-positive persons, the primary targets were those with “poor”
adherence (11 reports) and having a substance abuse problem (10 reports). In 9 reports, no
specific population target was identified other than being HIV-positive. Women were the sole
targets in 7 reports (including 1 report featuring women with substance abuse). Of the 40
remaining reports of studies with both men and women participants, in only 5 was sex
difference addressed in relation to outcomes; in none of these were sex differences found.
Also as shown in Table 1, 20 of the 47 intervention reports target one specific problem favoring
nonadherence, such as forgetting to take medications, depression, substance abuse, risky
behaviors, or low health literacy. The problem most targeted in these studies was substance
abuse (7 reports, excluding 2 reports that target persons with substance abuse but do not
explicitly present substance abuse as an adherence problem). In contrast, the remaining 27
reports target either no specific factor (18 reports) at all or multiple factors influencing
adherence (9 reports). The reports with no specific adherence factor identified typically contain
reviews of the interventions previously tested to enhance adherence, not of factors found to
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favor adherence or nonadherence. The reports featuring multiple factors contain reviews of a
host of factors shown or surmised to be related to nonadherence.
As shown in Tables 1 and 2, the interventions tested were either single- or multiple-component.
Single-component interventions addressed one domain, such as direct observation of behavior,
while multiple-component interventions addressed at least two domains, such as cognitive-
behavioral elements directed toward knowledge, beliefs, social support, and behavior.
Cognitive-behavioral interventions were the most prevalent interventions, used to address both
single problems favoring nonadherence (e.g., substance abuse) and multiple problems favoring
nonadherence (e.g., lack of knowledge, forgetting, low self-efficacy).
As shown in Table 2, the most prevalent problem-intervention combination was the no specific
problem/multiple-component intervention (16 reports), followed by the single problem/single-
component intervention (12 reports), multiple problem/multiple-component intervention (9
reports), single problem/multiple-component intervention (8 reports), no specific problem/
single-component (3 reports, including 1 report testing a single- and a multiple-component
intervention), and multiple problem/single-component (1 report testing a single- and a multiple-
component intervention). Substance abuse is an example of a single problem addressed by
single- and multiple-component interventions, including direct observation or administration,
contingency management, and cognitive-behavioral therapies. Direct observation or
administration is an example of the same intervention tested to address multiple problems, no
specific problem (other than poor adherence), and one specific problem (substance abuse).
Discussion
Extent to Which Intervention Studies Targeted Factors Found to Influence Adherence
Substance abuse was prominent as a barrier to adherence in descriptive studies and as a target
of intervention in intervention studies. Family and provider support was prominent as a
facilitator of adherence in descriptive studies, while social support was an explicit intervention
component in 12 of the intervention studies and an outcome variable in one additional study.
Social support was an implicit component in all of the interventions as any cognitive-behavioral
or psycho-educational intervention constitutes a kind of social support.
Side effects were the most prominent factor found to impede adherence, yet interventions to
target them were less discernible in the intervention reports. However, the reduction/
elimination of side effects may be more amenable to pharmacological than to cognitive-
behavioral or psycho-educational interventions directed toward managing side effects. Despite
the prominence of the social environment in facilitating or impeding adherence in the
descriptive studies, interventions were directed solely toward HIV-positive persons, not, for
example, the healthcare system or societal norms. Intervention components were largely in the
cognitive domain, even when directed toward non-cognitive elements as, for example, when
an educational, not a social, intervention was directed at teaching HIV-positive persons how
to mobilize social support.
Researchers have argued that the overly individualistic and rationalist orientation to
antiretroviral adherence cannot adequately address the “hybrid medico-experiential ways of
knowing” (Mykhalovskiy, 2008, p. 138) of HIV-positive persons; the daily “health
work” (Bresalier et al., 2002) of which antiretroviral adherence is only a part; the varieties of
strategic nonadherence that paradoxically permit overall adherence (Broyles, Colbert, & Erlen,
2005); and, the episodic, dose-by-dose nature of medicine taking (Ryan & Wagner, 2003;
Wilson, Hutchinson, & Holzemer, 2002). Both descriptive and intervention studies leaned
toward the cognitive, but that lean may not capture the ongoing work of medicine taking and
the larger sociocultural arena in which this work is embedded.
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Targeting, Tailoring, and Fidelity in Antiretroviral Intervention Studies
Our review raises questions regarding the nature of the interventions themselves. Multiple-
component interventions were typically presented in reports as especially suitable for
addressing the many factors operating against antiretroviral adherence under the apparent
assumption that complexity of problem must be matched to complexity of solution: that a
shotgun approach to intervention (i.e., involving multiple components, in addition to multiple
delivery channels and/or types of providers) will actually hit the one or more problems in play
for any one person receiving the intervention at any given time. In 27 of the 47 intervention
reports, either no specific problem or an array of problems influencing adherence were
addressed. Interventions targeting many problems at once are as non-specific as the ones
targeting no problem at all.
When authors described their interventions as tailored, they were most often actually referring
to targeting the problems identified by individual participants as impeding their adherence
(e.g., forgetting, lack of self-efficacy) with that component of the intervention that was to be
mobilized whenever that problem was identified (e.g., memory prompting, skill-building). In
some cases, they were referring to an intervention tailored to a particular medication regimen,
not a problem or person per se. Targeting and tailoring were further indistinct when researchers
described their interventions as intending to meet the special needs of entire social groups, such
as women, Latinos, or substance abusers. Researchers were here invoking what Epstein (2007,
Ch. 7) referred to as “niche standardization,” whereby both the universalism of assuming that
all HIV-positive people are the same, and the individualism of assuming that HIV-positive
persons share no common ground with each other, are avoided. Tailoring in the intervention
studies reviewed involved interventions delivered to individuals seen to have one primary
group membership. At issue is which niches are the least likely to minimize differences
essential to enhancing antiretroviral adherence.
The essential incompatibility between intervention tailoring and fidelity (a demonstration that
an intervention was delivered as planned) complicates the implementation of tailored
interventions. In most cases of tailoring, interventions were customized in a scripted way: for
example, if the person expressed a knowledge deficit, the intervention protocol dictated what
the interventionist was to do or say to reduce it. Unclear was how far tailoring could go before
intervention fidelity was undermined. Intervention fidelity was addressed in 17 of the 27 reports
of tailored interventions, but in none of them was the incongruity addressed between the
tailoring of interventions and the standardization of interventions required to optimize
intervention fidelity.
This raises the questions of how tailored an intervention can be before intervention fidelity is
impossible to achieve and researchers can no longer claim they tested any one intervention at
all, and whether any multiple-component intervention can be tested as a single experimental
condition. Although tailored interventions have been found to be generally superior to control
conditions (Richards et al., 2007), yet to be sufficiently differentiated in intervention research
is whether it was the content, function, or form of the intervention that was standardized or,
conversely, altered to fit (Campbell et al., 2000; Castro, Barrera, & Martinez, 2004; Hawe,
Shiell, & Riley, 2004) some individual, social group, or situation. In tailored intervention
studies, outcomes would need to be differentiated by the problem identified and the intervention
component implemented in response to that problem.
In conclusion, our review suggests some congruence between factors targeted in antiretroviral
adherence intervention studies and those identified in descriptive studies as influencing
adherence. Lack of congruence may be due to the complex nature of the adherence problem,
individualistic and rationalist orientation toward intervention, or simply the way interventions
were presented. Our review also raises questions about the relationships among intervention
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tailoring, targeting, and fidelity and, in the case of antiretroviral adherence interventions in
particular, about how interventions are best structured to capture the ongoing work of adherence
and variations in participants, social environment, and type of medication regimen, and to
maximize the ability to draw credible conclusions about the effectiveness of interventions for
achieving desirable adherence rates.
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Table 2
Combinations of Single v. Multiple Problems and Single v. Multiple Component Interventions
Problem(s)
Single problem No specific (NS) or multiple (M) problems
Intervention component(s)
Single-component Depression/antidepressants (Dalessandro et
al.)
NS/direct observation or administration (Garland et al; Harwell et al.;
Wohl et al.a)
Forgetting/memory prompting device
(Andrade et al.; Safren et al.)
M/direct observation or administration (Visnegarwala et al.a)
Substance abuse/direct observation or
administration (Lucas et al., 2006, 2007;




Discovery of meaning/writing (Westling et
al.)
Adherence to dose interval/cue-dose training
(Rigsby et al.)
Routinization of therapy/memory prompting
device (Puccio et al.)
Multiple-component Low literacy/cognitive-behavioral
(Kalichman et al.)
NS/M (Collier et al.; DeFino et al.; Dieckhaus et al.; Golin et al.; Levin
et al.; Mannheimer et al.; Milam et al.; Murphy, Lu, et al., 2002; Murphy,
Marelich, et al., 2007; Rathbun et al.; Remien et al.; Reynolds et al.; Rosen
et al.; Wagner et al.; Williams et al.; Wohl et al.a)
Self-efficacy/cognitive-behavioral (Ironson
et al.; Smith et al.)
Substance abuse/cognitive-behavioral
(Parsons et al.; Samet et al.)
Risk behaviors/cognitive-behavioral
(Margolin et al.; Wyatt et al.)
M/M (DiIorio et al.; Holzemer et al.; Javanbakht et al.; Jones et al.; Lyon
et al; Parry et al.; Simoni et al.; van Servellen et al.; Visnegarwala et
al.a)
Under-represented in research/education and
empowerment counseling (Rawlings et al.)
a
Note. In these studies, two interventions were tested in addition to a standard-of-care condition.
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